Figure S3 from APR-246 Enhances Colorectal Cancer Sensitivity to Radiotherapy
<p>Supplementary figure 3</p>
Xiao-Feng Sun +10 more
openaire +1 more source
Figure S4 from APR-246 Enhances Colorectal Cancer Sensitivity to Radiotherapy
<p>Supplementary figure 4</p>
Xiao-Feng Sun +10 more
openaire +1 more source
The next steps in improving the outcomes of advanced ovarian cancer [PDF]
Worldwide ovarian cancer affects over 200,000 women per year. Overall survival rates are poor due to two predominate reasons. First, the majority of patients present with advanced disease creating significant difficulty with effecting disease eradication.
Blagden, S +3 more
core +1 more source
Figure S5 from APR-246 Enhances Colorectal Cancer Sensitivity to Radiotherapy
<p>Supplementary figure 5</p>
Xiao-Feng Sun +10 more
openaire +1 more source
Figure S1 from APR-246 enhances colorectal cancer sensitivity to radiotherapy
<p>Supplementary figure 1</p>
Xiao-Feng Sun +10 more
openaire +1 more source
Figure S6 from APR-246 enhances colorectal cancer sensitivity to radiotherapy
<p>Supplementary figure 6</p>
Xiao-Feng Sun +10 more
openaire +1 more source
Figure S9 from APR-246 Enhances Colorectal Cancer Sensitivity to Radiotherapy
<p>Supplementary figure 9</p>
Xiao-Feng Sun +10 more
openaire +1 more source
Figure S8 from APR-246 Enhances Colorectal Cancer Sensitivity to Radiotherapy
<p>Supplementary figure 8</p>
Xiao-Feng Sun +10 more
openaire +1 more source
Mechanisms of p53-mediated intrinsic and extrinsic tumor suppression [PDF]
p53 is a promising target for cancer therapy. However, the molecular basis of the p53 tumor suppression function remains incompletely understood.
Li, Hai
core +1 more source
PRIMA-1Met suppresses colorectal cancer independent of p53 by targeting MEK [PDF]
This work was supported by Grant No. 81201779 (Hua Xiong) from the National Natural Science Youth Foundation; Grant No. 81502118 (Yanmei Zou) from the National Natural Science Youth Foundation; Grant No.
Duan, Qiuhong +15 more
core +2 more sources

